Autoimmune liver disease in children

Annals of the Academy of Medicine Singapore

Volumn 32, Issue 2, 2003, Pages 239-243

  Mieli Vergani, Giorgina ^a   Vergani, D ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Autoantibodies; Hepatitis; Sclerosing cholangitis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; MICROSOME ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; SMOOTH MUSCLE ANTIBODY; URSODEOXYCHOLIC ACID;

ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; BONE MARROW SUPPRESSION; CHILD; CHILDHOOD DISEASE; CHOLANGIOGRAPHY; CLINICAL FEATURE; CONFERENCE PAPER; DIARRHEA; FAMILY HISTORY; HUMAN; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LIVER DISEASE; LIVER HISTOLOGY; LIVER TOXICITY; NAUSEA; PROGNOSIS; REMISSION; SCLEROSING CHOLANGITIS; SEX RATIO; VERTIGO; VOMITING;

EID: 0038344157     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Johnson P J, McFarlane I G. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18:998-1005.
2. Alvarez F, Berg P A, Bianchi F B, Bianchi L, Burroughs A K, Cancado E L, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.
3. Maggiore G, Veber F, Bernard O, Hadchouel M, Homberg J C, Alvarez F, et al. Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents. J Pediatr Gastroenterol Nutr 1993; 17:376-81.
4. Gregorio G V, Portmann B, Reid F, Donaldson P T, Doherty D G, McCartney M, et al. Autoimmune hepatitis in childhood: a 20-year experience. Hepatology 1997; 25:541-7.
5. Homberg J C, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil S H, et al. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology 1987; 7:1333-9.
6. Johnson P J, McFarlane I G, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 1995; 333:958-63.
7. Alvarez F, Ciocca M, Canero-Velasco C, Ramonet M, de Davila M T, Cuarterolo M, et al. Short-term cyclosporine induces a remission of autoimmune hepatitis in children. J Hepatol 1999; 30:222-7.
8. Richardson P D, James P D, Ryder S D. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine. J Hepatol 2000; 33:371-5.
9. Dhawan A, Mieli-Vergani G. Mycophenolate mofetil - a new treatment for autoimmune hepatitis? J Hepatol 2000; 33:480-1.
10. Maggiore G, Bernard O, Hadchouel M, Alagille D. Life-saving immunosuppressive treatment in severe autoimmune chronic active hepatitis. J Pediatr Gastroenterol Nutr 1985; 4:655-8.
11. Debray D, Maggiore G, Girardet J P, Mallet E, Bernard O. Efficacy of cyclosporin A in children with type 2 autoimmune hepatitis. J Pediatr 1999; 135:111-4.
12. Gohlke F, Lohse A W, Dienes H P, Lohr H, Marker-Hermann E, Gerken G, et al. Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol 1996; 24:699-705.
13. el-Shabrawi M, Wilkinson M L, Portmann B, Mieli-Vergani G, Chong S K, Williams R, et al. Primary sclerosing cholangitis in childhood. Gastroenterology 1987; 92(5 Pt 1):1226-35.
14. Wilschanski M, Chait P, Wade J A, Davis L, Corey M, St Louis P, et al. Primary sclerosing cholangitis in 32 children: clinical, laboratory, and radiographic features, with survival analysis. Hepatology 1995; 22: 1415-22.
15. Gregorio G V, Portmann B, Karani J, Harrison P, Donaldson P T, Vergani D, et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 2001; 33:544-53.
16. Czaja A J. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology 1998; 28:360-5.
17. Lee Y M, Kaplan M M. Primary sclerosing cholangitis. N Engl J Med 1995; 332:924-33.
18. Beuers U, Spengler U, Kruis W, Aydemir U, Wiebecke B, Heldwein W, et al. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology 1992; 16:707-14.
19. Lebovics E, Salama M, Elhosseiny A, Rosenthal W S. Resolution of radiographic abnormalities with ursodeoxycholic acid therapy of primary sclerosing cholangitis. Gastroenterology 1992; 102:2143-7.
20. Lindor K D. Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. N Engl J Med 1997; 336:691-5.
21. Ma Y, Gaken J, McFarlane B M, Foss Y, Farzaneh F, McFarlane I G, et al. Alcohol dehydrogenase: a target of humoral autoimmune response in liver disease. Gastroenterology 1997; 112:483-92.
22. Ma Y, Bogdanos B P, Williams R, Mieli-Vergani G, Vergani D. Anti-SLA antibody is a marker of severity of liver damage in patients with autoimmune liver disease. J Hepatol 2001; 34(Suppl 1):212.
23. Mieli-Vergani G, Lobo-Yeo A, McFarlane B M, McFarlane I G, Mowat A P, Vergani D. Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood. Hepatology 1989; 9:198-203.